Skip to content

Needle Radiofrequency Treatment for Submental Fat

Efficacy and Safety of the Micro-insulated Needle Radiofrequency Device for Reduction of Submental Fat

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05517824
Enrollment
24
Registered
2022-08-26
Start date
2021-06-07
Completion date
2021-11-04
Last updated
2022-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obese

Brief summary

The investigators aimed to evaluate the efficacy and safety of a fractional radiofrequency device with a micro-insulated needle to reduce submental fat.

Interventions

PROCEDUREmicroinsulated needle radiofrequency

A single treatment using a microinsulated needle radiofrequency device

Sponsors

Seoul National University Bundang Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

prospective, single-blinded, pre-post comparative study

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients with excess submental fat on a grade of 1\ 4, as assessed by the Physician-Assisted Submental Fat Rating Scale

Exclusion criteria

* mental impairment, infectious disease * history of keloid development * pregnancy, pacemaker * use of anticoagulants * undergoing a facelift procedure within the prior 6 months.

Design outcomes

Primary

MeasureTime frameDescription
Physician-Assisted Submental Fat Rating Scale score from 0 (nothing) to 4 (very severe)1 month after the treatmentsubmental fat rating by an independent investigator

Secondary

MeasureTime frameDescription
submental fat volume (cc)1 month after the treatmentfat volume quantified with a three-dimensional camera
patient satisfaction score from 0 (not satisfied) to 10 (most satisfied)1 month after the treatmentpatient's satisfaction score for reduction of submental fat
any adverse effects at any time during or after treatmentassessed through study completion, an average of 2 monthsadverse events

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026